» Articles » PMID: 30945476

Evaluation of a Mobile C-arm Cone-beam CT in Interstitial High-dose-rate Prostate Brachytherapy Treatment Planning

Overview
Date 2019 Apr 5
PMID 30945476
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The aim of this study was to evaluate the suitability of using cone-beam computed tomography (CBCT) obtained with a mobile C-arm X-ray fluoroscopy unit as a single modality for planning of high-dose-rate (HDR) prostate brachytherapy treatments.

Methods: The feasibility of using CBCT images obtained using a Siemens Arcadis Orbic 3D mobile C-arm was evaluated. A retrospective clinical study was undertaken of six participants undergoing HDR prostate brachytherapy. Plans generated using images from a Toshiba Aquilion One LB CT were compared with those generated using CBCT images. After rigid spatial registration, the plans were compared based on various parameters such as dose-volume histograms, overlap quantities and metrics, and dose constraints.

Results: Provided they were within the limited field of view, the brachytherapy catheters and fiducial markers were clearly visible in the CBCT images and thus, localisable and identifiable in the treatment planning process. The Siemens CBCT underestimated CT numbers leading to poorer tissue contrast which exacerbated the difficulties in delineation of the target tumour and the surrounding organs at risk. Between CT- and CBCT-based plans, the mean difference of CTV-D was 1.58 Gy, CTV-V was 12.13%, rectum-V was 0.06% and urethra-V was -0.70%.

Conclusion: It was not feasible to solely utilise the Siemens Arcadis Orbic 3D for HDR prostate brachytherapy treatment planning due to suboptimal organ delineation. However, the methods in this study could be used to evaluate other mobile CBCT imaging devices for feasibility in HDR brachytherapy treatment planning since the results indicated that it may not be necessary to have standard quality CT images for treatment planning.

Citing Articles

Development and validation of a scatter-corrected CBCT image-guided method for cervical cancer brachytherapy.

Wu A, Cui H, Jiang X, Yan B, Wu A, Liu Y Front Oncol. 2022; 12:942016.

PMID: 36387118 PMC: 9647154. DOI: 10.3389/fonc.2022.942016.


Quality assurance and long-term stability of a novel 3-in-1 X-ray system for brachytherapy.

Karius A, Szkitsak J, Boronikolas V, Fietkau R, Bert C J Appl Clin Med Phys. 2022; 23(9):e13727.

PMID: 35848090 PMC: 9512339. DOI: 10.1002/acm2.13727.


Evaluation of a mobile C-arm cone-beam CT in interstitial high-dose-rate prostate brachytherapy treatment planning.

Djukelic M, Waterhouse D, Toh R, Tan H, Rowshanfarzad P, Joseph D J Med Radiat Sci. 2019; 66(2):112-121.

PMID: 30945476 PMC: 6545480. DOI: 10.1002/jmrs.331.

References
1.
Even A, Nuver T, Westendorp H, Hoekstra C, Slump C, Minken A . High-dose-rate prostate brachytherapy based on registered transrectal ultrasound and in-room cone-beam CT images. Brachytherapy. 2013; 13(2):128-36. DOI: 10.1016/j.brachy.2013.08.001. View

2.
Djukelic M, Waterhouse D, Toh R, Tan H, Rowshanfarzad P, Joseph D . Evaluation of a mobile C-arm cone-beam CT in interstitial high-dose-rate prostate brachytherapy treatment planning. J Med Radiat Sci. 2019; 66(2):112-121. PMC: 6545480. DOI: 10.1002/jmrs.331. View

3.
DuBois D, Prestidge B, Hotchkiss L, Prete J, Bice Jr W . Intraobserver and interobserver variability of MR imaging- and CT-derived prostate volumes after transperineal interstitial permanent prostate brachytherapy. Radiology. 1998; 207(3):785-9. DOI: 10.1148/radiology.207.3.9609905. View

4.
Al-Halabi H, Portelance L, Duclos M, Reniers B, Bahoric B, Souhami L . Cone beam CT-based three-dimensional planning in high-dose-rate brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phys. 2009; 77(4):1092-7. DOI: 10.1016/j.ijrobp.2009.06.036. View

5.
Scarfe W, Farman A . What is cone-beam CT and how does it work?. Dent Clin North Am. 2008; 52(4):707-30, v. DOI: 10.1016/j.cden.2008.05.005. View